Qingbin Yao

22 Qixiangtai Road
Tianjin, 300070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization.

lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization.

Journal: Cellular & molecular biology letters

Published: June 19, 2023

LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway.

LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway.

Journal: BMC medicine

Published: April 07, 2022

STARD5 as a potential clinical target of hepatocellular carcinoma.

STARD5 as a potential clinical target of hepatocellular carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: January 26, 2022

1α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway.

1α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway.

Journal: Biochemical and biophysical research communications

Published: May 30, 2019

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition.

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition.

Journal: Theranostics

Published: May 23, 2019

SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker.

SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker.

Journal: Theranostics

Published: January 08, 2019

Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling.

Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling.

Journal: Biochemical and biophysical research communications

Published: September 24, 2017

BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.

BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 01, 2017

The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-κB-dependent manner.

The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-κB-dependent manner.

Journal: The FEBS journal

Published: November 04, 2016

The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways.

The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways.

Journal: Nature communications

Published: July 06, 2016

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation.

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation.

Journal: Scientific reports

Published: May 10, 2016

G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway.

G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway.

Journal: Oncotarget

Published: April 16, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026